Novabay Pharmaceuticals IncのFCF yield
Novabay Pharmaceuticals IncのFCF yieldは何ですか。
Novabay Pharmaceuticals IncのFCF yieldは-87.25%です。
FCF yieldの定義は何ですか。
Free cash flow yield (FCF yield) is a financial ratio that compares the free cash flow per share to the market value per share. The ratio is calculated by dividing free cash flow per share by the current share price.
ttm (trailing twelve months)
Free cash flow yield is a good measure of the company’s cash flow in respect to the company’s size. Larger companies tend to have a higher cash flow yield, but it’s not always the case. The higher the free cash flow yield, the more cash the company is generating that can be quickly accessed to satisfy its obligations. The lower the free cash flow yield, the more money investors are putting into the company with little result. The higher the ratio, the more attractive the investment is as it suggests that investors are paying less for each unit of free cash flow.
Free cash flow acts as an indicator of how capable a company is of repaying all of its obligations. It is a solid indicator of how financially stable a company is. It is calculated as:
Free cash flow yield = Free cash flow per share / market price per share
NYSEMKTのセクタHealth CareにおけるFCF yieldの企業と比べるNovabay Pharmaceuticals Inc
Novabay Pharmaceuticals Incは何をしますか。
novabay pharmaceuticals $nby is a biopharmaceutical company focusing, commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the global eye care market. novabay has two distinct product categories: the neutrox™ family of products, led by avenova™ for the eye care market, neutrophase® for wound care, and cellerx™ for the dermatology market; and aganocide® compounds, led by auriclosene™. novabay is commercializing avenova, a prescription lid and lash hygiene product for the management of the chronic eye conditions of blepharitis and meibomian gland dysfunction – also known as dry eye syndrome. these difficult-to-manage conditions affect approximately 30 million americans, with an annual market potential that novabay estimates at $500 million. novabay is gaining market traction with avenova through its 35-medical direct sales representatives under veteran leadership. avenova is available for order in 90% of all pharmacies across
Novabay Pharmaceuticals Incと類似のfcf yield
- Eve & CoのFCF yieldは-87.69%です。
- Arbuthnot Banking PLCのFCF yieldは-87.63%です。
- Quadro ResourcesのFCF yieldは-87.58%です。
- Earth Alive Clean TechnologiesのFCF yieldは-87.57%です。
- Bancolombia S.AのFCF yieldは-87.49%です。
- Avocent CorpのFCF yieldは-87.41%です。
- Novabay Pharmaceuticals IncのFCF yieldは-87.25%です。
- SPI Co LtdのFCF yieldは-87.08%です。
- Arctic Star ExplorationのFCF yieldは-87.06%です。
- CemtrexのFCF yieldは-86.86%です。
- PilotのFCF yieldは-86.76%です。
- SpareBank 1 OstlandetのFCF yieldは-86.73%です。
- Panda GreenのFCF yieldは-86.68%です。